Our current results also showed that Fgf21 was significantly upregulated in the DIO + DHA group, suggesting that the beneficial effects of this n-3 PUFA on age and obesity-related MASLD could be mediated, at least in part, by Fgf21 upregulation. Here, FGF21 is linked to obesity disorder.